Northwestern University: Central Nervous System Neoplasms trials
The registry lists 11 Central Nervous System Neoplasms studies with Northwestern University as lead sponsor. 0 are open to participants now and 4 have results posted.
Early Phase 1 2Phase 1 2Phase 2 6No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & TemozolomideCompletedNCT00990652Phase 2Results posted
- Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00720356Phase 2Results posted
- Vatalanib in Treating Patients With Recurrent or Progressive MeningiomaCompletedNCT00348790Phase 2Results posted
- Bevacizumab in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00337207Phase 2Results posted
- Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSLWithdrawnNCT00734773Early Phase 1
- VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant GliomaTerminatedNCT00516282Phase 1
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
- Levetiracetam in Treating Patients With Seizures Caused by Brain MetastasesWithdrawnNCT00415376Not applicable
- Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain MetastasesStatus unknownNCT00276783Phase 2
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By SurgeryStatus unknownNCT00275067Phase 1/2
- Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWithdrawnNCT00005790Not applicable